Torrent Pharmaceuticals has officially published the complete Transcript of the Conference call held with Analysts and Investors. This call discussed the company’s financial results for the quarter and the nine months ending 31st December, 2025. In compliance with disclosure norms, the transcript has been made available on the official company website for public access and review by all stakeholders, effective from February 20, 2026.
Official Disclosure of Financial Call Transcript
Torrent Pharmaceuticals Limited issued a formal communication on 20th February, 2026, regarding compliance requirements related to recent financial performance disclosures. This letter was addressed to the Listing Departments of both the BSE Limited and the National Stock Exchange of India Ltd.
Subject of Disclosure
The primary purpose of the communication was to announce the formal placement of the Transcript of the Conference call conducted with Analysts and Investors. This discussion focused exclusively on the review of the Company’s financial results for two key periods: the quarter ended 31st December, 2025, and the nine months concluded on the same date.
Transcript Availability
In accordance with applicable listing regulations, the full transcript document has been uploaded and is now accessible on the official Torrent Pharma website. Stakeholders can find the document using the following direct link: https://torrentpharma.com/pdf/investors/Q3-FY25-26_Earnings-Call-Transcript.pdf. The company requested that the stock exchanges take this public filing on record.
Source: BSE
